CGIX | Cancer Genetics Inc. Financial Vitals | US News ... Financial summary and company information for Cancer Genetics Inc. CGIX Analysts' recommendations provided by ZACKS Investment Research, Inc. Analysts Don’t let stock market panic make CGIX Price Target - ETF Channel The median CGIX price target (a different metric than the average or mean) was $ as of 2020-03-01, the highest CGIX price target in the range was $ while the lowest CGIX price target in the range was $, with a standard deviation of $. Get the latest Zacks research report on CGIX — FREE. 10 ETFs With Most Upside To Analyst Targets Cancer Genetics Inc. (Nasdaq: CGIX) :: LD Micro Oct 24, 2019 · Rutherford, N.J, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in proprietary preclinical test systems supporting drug discovery and development at early stages, valued by the pharmaceutical industry, biotechnology companies and academic research centers, today announced, among others, the completion of Cancer Genetics (CGIX) Looks Good: Stock Rises 8%
View Cancer Genetics, Inc. CGIX investment & stock information. Get the latest Cancer Genetics, Inc. CGIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
CGIX Stock News and Research Articles | Cancer Genetics ... Cancer Genetics Inc. shareholders must certainly be pleased with the stock performance during the prior three trading days.Shares of Cancer Genetics closed higher by over 29%, ending the regular trading session at $5.05 per share on Monday. Since the start of … Cancer Genetics Inc. CGIX - Quotes, Financials, News ... Cancer Genetics Inc. CGIX Overview. Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Don’t let stock CGIX Institutional Ownership - Cancer Genetics, Inc. Stock
Apr 01, 2020 · Stock quote and company snapshot for CANCER GENETICS INC (CGIX), including profile, stock chart, recent news and events, analyst opinions, and research reports.
Cancer Genetics, Inc. Common Stock (CGIX) Real-Time Stock ... CGIX's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low CGIX Cancer Genetics, Inc. Stock Quote - FINVIZ.com
View Cancer Genetics, Inc. CGIX investment & stock information. Get the latest Cancer Genetics, Inc. CGIX detailed stock quotes, stock data, Real-Time ECN,
Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields in the United States, Europe, and the Asia Pacific. CGIX - Cancer Genetics Stock Price - Barchart.com For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. Cancer Genetics, Inc. Common Stock (CGIX) Earnings Report ... Mar 20, 2020 · Find the latest Earnings Report Date for Cancer Genetics, Inc. Common Stock (CGIX) at Nasdaq.com. Looking for additional market data? Visit Our vendor, Zacks Investment Research, hasn't CGIX Stock Quote - Cancer Genetics, Inc. Common Stock ... Stock quote for Cancer Genetics, Inc. Common Stock Common Stock (CGIX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
CGIX Stock Price | Cancer Genetics Inc. Stock Quote (U.S ...
Dec 11, 2014 · Cancer Genetics, Inc. was a big mover last session with its shares rising just over 8% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost over 7% in the past one-month time frame. Cancer Genetics: 3Q Earnings Snapshot Nov 20, 2019 · RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Wednesday reported third-quarter net income of $2 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Rutherford, New Jersey-based company said it had net income of 98 cents. Losses, adjusted for one-time gains and costs, came to 32 cents per share.
View Cancer Genetics, Inc. CGIX investment & stock information. Get the latest Cancer Genetics, Inc. CGIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. All News for CGIX : Cancer Genetics, Inc. - Zacks.com Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. CGIX Stock Price, Forecast & News (Cancer Genetics) Cancer Genetics Inc (NASDAQ:CGIX) released its quarterly earnings data on Tuesday, April, 16th. The medical research company reported ($0.14) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.16) by $0.02. CGIX Stock Price | Cancer Genetics Inc. Stock Quote (U.S ... CGIX | Complete Cancer Genetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.